10 XP 0   0   5  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Bristol-Myers Squibb Company
Buy, Hold or Sell?

Let's analyze Bristol-Myers Squibb Company together

I guess you are interested in Bristol-Myers Squibb Company. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Bristol-Myers Squibb Company. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Bristol-Myers Squibb Company

I send you an email if I find something interesting about Bristol-Myers Squibb Company.

1. Quick Overview

1.1. Quick analysis of Bristol-Myers Squibb Company (30 sec.)










1.2. What can you expect buying and holding a share of Bristol-Myers Squibb Company? (30 sec.)

How much money do you get?

How much money do you get?
€2.59
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
€8.41
Expected worth in 1 year
€1.59
How sure are you?
75.0%

+ What do you gain per year?

Total Gains per Share
€-4.48
Return On Investment
-9.9%

For what price can you sell your share?

Current Price per Share
€45.10
Expected price per share
€41.53 - €48.78
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Bristol-Myers Squibb Company (5 min.)




Live pricePrice per Share (EOD)
€45.10
Intrinsic Value Per Share
€15.95 - €60.64
Total Value Per Share
€24.36 - €69.05

2.2. Growth of Bristol-Myers Squibb Company (5 min.)




Is Bristol-Myers Squibb Company growing?

Current yearPrevious yearGrowGrow %
How rich?$18.8b$35.3b-$9.8b-38.6%

How much money is Bristol-Myers Squibb Company making?

Current yearPrevious yearGrowGrow %
Making money-$1.6b$1.9b-$3.6b-221.7%
Net Profit Margin-13.4%17.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Bristol-Myers Squibb Company (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Bristol-Myers Squibb Company?

Welcome investor! Bristol-Myers Squibb Company's management wants to use your money to grow the business. In return you get a share of Bristol-Myers Squibb Company.

First you should know what it really means to hold a share of Bristol-Myers Squibb Company. And how you can make/lose money.

Speculation

The Price per Share of Bristol-Myers Squibb Company is €45.10. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bristol-Myers Squibb Company.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bristol-Myers Squibb Company, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €8.41. Based on the TTM, the Book Value Change Per Share is €-1.71 per quarter. Based on the YOY, the Book Value Change Per Share is €0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.59 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bristol-Myers Squibb Company.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.831.8%-0.81-1.8%0.942.1%0.050.1%0.220.5%
Usd Book Value Change Per Share0.280.6%-1.89-4.2%0.010.0%0.020.1%0.020.1%
Usd Dividend Per Share0.661.5%0.651.4%0.611.4%0.561.2%0.451.0%
Usd Total Gains Per Share0.942.1%-1.24-2.7%0.621.4%0.581.3%0.471.1%
Usd Price Per Share43.43-52.75-72.89-61.83-59.56-
Price to Earnings Ratio13.11-10.46-19.94--7.50-48.05-
Price-to-Total Gains Ratio46.22--2.68--274.31-64.79-82.67-
Price to Book Ratio4.67-4.48-4.38-3.78-6.04-
Price-to-Total Gains Ratio46.22--2.68--274.31-64.79-82.67-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share49.8435035
Number of shares20
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.650.56
Usd Book Value Change Per Share-1.890.02
Usd Total Gains Per Share-1.240.58
Gains per Quarter (20 shares)-24.7611.61
Gains per Year (20 shares)-99.0446.44
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
152-151-10944236
2104-302-20889482
3156-453-3071336128
4207-604-4061788174
5259-754-50522210220
6311-905-60426712266
7363-1056-70331114312
8415-1207-80235616358
9467-1358-90140018404
10518-1509-100044520450

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%11.01.00.091.7%15.05.00.075.0%32.08.00.080.0%126.012.00.091.3%
Book Value Change Per Share2.02.00.050.0%7.05.00.058.3%10.010.00.050.0%21.019.00.052.5%87.050.01.063.0%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%138.00.00.0100.0%
Total Gains per Share2.02.00.050.0%8.04.00.066.7%14.06.00.070.0%30.010.00.075.0%105.033.00.076.1%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Bristol-Myers Squibb Company compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.250-1.706+782%0.010+2426%0.022+1022%0.021+1111%
Book Value Per Share--8.41311.290-25%15.055-44%15.896-47%11.418-26%
Current Ratio--1.1561.218-5%1.368-16%1.550-25%1.729-33%
Debt To Asset Ratio--0.8200.756+8%0.666+23%0.676+21%0.619+32%
Debt To Equity Ratio--4.5593.484+31%2.000+128%2.244+103%1.749+161%
Dividend Per Share--0.6000.586+2%0.553+8%0.503+19%0.408+47%
Eps--0.749-0.734+198%0.850-12%0.046+1537%0.203+270%
Free Cash Flow Per Share--1.0171.585-36%1.261-19%1.433-29%0.914+11%
Free Cash Flow To Equity Per Share---0.9662.389-140%-0.269-72%0.478-302%0.464-308%
Gross Profit Margin--1.0000.591+69%0.225+345%1.615-38%-1.282+228%
Intrinsic Value_10Y_max--60.637--------
Intrinsic Value_10Y_min--15.952--------
Intrinsic Value_1Y_max--5.981--------
Intrinsic Value_1Y_min--3.329--------
Intrinsic Value_3Y_max--18.043--------
Intrinsic Value_3Y_min--8.562--------
Intrinsic Value_5Y_max--30.193--------
Intrinsic Value_5Y_min--12.178--------
Market Cap91425600113.920+13%79719410000.00097337436698.400-18%140020430000.000-43%120489588707.808-34%113076138048.077-29%
Net Profit Margin--0.138-0.134+197%0.176-22%0.014+869%0.086+61%
Operating Margin--0.2130.188+13%0.216-2%0.176+21%0.201+6%
Operating Ratio--0.8590.847+1%0.820+5%0.850+1%0.832+3%
Pb Ratio5.360+13%4.6704.480+4%4.383+7%3.776+24%6.038-23%
Pe Ratio15.050+13%13.11310.463+25%19.940-34%-7.500+157%48.053-73%
Price Per Share45.095+13%39.29047.723-18%65.950-40%55.944-30%53.885-27%
Price To Free Cash Flow Ratio11.083+13%9.6568.019+20%13.776-30%10.703-10%17.613-45%
Price To Total Gains Ratio53.044+13%46.216-2.683+106%-274.311+694%64.793-29%82.672-44%
Quick Ratio--0.8091.004-19%1.168-31%1.384-42%1.689-52%
Return On Assets--0.016-0.014+189%0.019-15%0.002+620%0.014+17%
Return On Equity--0.089-0.112+226%0.057+58%-0.007+108%0.020+346%
Total Gains Per Share--0.850-1.120+232%0.563+51%0.525+62%0.429+98%
Usd Book Value--18866365700.00025467217300.000-26%35305492600.000-47%38065205640.000-50%26841188097.500-30%
Usd Book Value Change Per Share--0.277-1.886+782%0.011+2426%0.025+1022%0.023+1111%
Usd Book Value Per Share--9.29812.478-25%16.640-44%17.570-47%12.620-26%
Usd Dividend Per Share--0.6630.648+2%0.611+8%0.556+19%0.451+47%
Usd Eps--0.828-0.812+198%0.939-12%0.051+1537%0.224+270%
Usd Free Cash Flow--2281339200.0003577027125.000-36%2962204000.000-23%3420848235.000-33%2155611325.000+6%
Usd Free Cash Flow Per Share--1.1241.752-36%1.394-19%1.584-29%1.011+11%
Usd Free Cash Flow To Equity Per Share---1.0672.641-140%-0.298-72%0.528-302%0.513-308%
Usd Market Cap101052715805.916+13%88113863873.000107587068782.742-18%154764581279.000-43%133177142398.740-34%124983055384.539-29%
Usd Price Per Share49.844+13%43.42752.748-18%72.895-40%61.835-30%59.559-27%
Usd Profit--1679941048.800-1635192619.078+197%1990680144.583-16%119845794.464+1302%457008962.993+268%
Usd Revenue--12200571866.91011626841999.798+5%11296353597.043+8%10903917368.113+12%7944271225.741+54%
Usd Total Gains Per Share--0.940-1.238+232%0.622+51%0.580+62%0.474+98%
 EOD+4 -4MRQTTM+17 -19YOY+13 -235Y+16 -2010Y+22 -14

3.3 Fundamental Score

Let's check the fundamental score of Bristol-Myers Squibb Company based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1515.050
Price to Book Ratio (EOD)Between0-15.360
Net Profit Margin (MRQ)Greater than00.138
Operating Margin (MRQ)Greater than00.213
Quick Ratio (MRQ)Greater than10.809
Current Ratio (MRQ)Greater than11.156
Debt to Asset Ratio (MRQ)Less than10.820
Debt to Equity Ratio (MRQ)Less than14.559
Return on Equity (MRQ)Greater than0.150.089
Return on Assets (MRQ)Greater than0.050.016
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Bristol-Myers Squibb Company based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.830
Ma 20Greater thanMa 5043.807
Ma 50Greater thanMa 10041.314
Ma 100Greater thanMa 20040.645
OpenGreater thanClose44.940
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Bristol-Myers Squibb Company

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Fundamental data was last updated by Penke on 2024-08-28 08:54:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Bristol-Myers Squibb Company earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Bristol-Myers Squibb Company to the Drug Manufacturers - General industry mean.
  • A Net Profit Margin of 13.8% means that €0.14 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bristol-Myers Squibb Company:

  • The MRQ is 13.8%. The company is making a huge profit. +2
  • The TTM is -13.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ13.8%TTM-13.4%+27.2%
TTM-13.4%YOY17.6%-31.0%
TTM-13.4%5Y1.4%-14.8%
5Y1.4%10Y8.6%-7.2%
4.3.1.2. Return on Assets

Shows how efficient Bristol-Myers Squibb Company is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Bristol-Myers Squibb Company to the Drug Manufacturers - General industry mean.
  • 1.6% Return on Assets means that Bristol-Myers Squibb Company generated €0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bristol-Myers Squibb Company:

  • The MRQ is 1.6%. Using its assets, the company is less efficient in making profit.
  • The TTM is -1.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ1.6%TTM-1.4%+3.0%
TTM-1.4%YOY1.9%-3.3%
TTM-1.4%5Y0.2%-1.6%
5Y0.2%10Y1.4%-1.1%
4.3.1.3. Return on Equity

Shows how efficient Bristol-Myers Squibb Company is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Bristol-Myers Squibb Company to the Drug Manufacturers - General industry mean.
  • 8.9% Return on Equity means Bristol-Myers Squibb Company generated €0.09 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bristol-Myers Squibb Company:

  • The MRQ is 8.9%. Using its investors money, the company is less efficient in making profit.
  • The TTM is -11.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ8.9%TTM-11.2%+20.2%
TTM-11.2%YOY5.7%-16.9%
TTM-11.2%5Y-0.7%-10.5%
5Y-0.7%10Y2.0%-2.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Bristol-Myers Squibb Company.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Bristol-Myers Squibb Company is operating .

  • Measures how much profit Bristol-Myers Squibb Company makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Bristol-Myers Squibb Company to the Drug Manufacturers - General industry mean.
  • An Operating Margin of 21.3% means the company generated €0.21  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bristol-Myers Squibb Company:

  • The MRQ is 21.3%. The company is operating efficient. +1
  • The TTM is 18.8%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ21.3%TTM18.8%+2.5%
TTM18.8%YOY21.6%-2.8%
TTM18.8%5Y17.6%+1.2%
5Y17.6%10Y20.1%-2.5%
4.3.2.2. Operating Ratio

Measures how efficient Bristol-Myers Squibb Company is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • An Operation Ratio of 0.86 means that the operating costs are €0.86 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Bristol-Myers Squibb Company:

  • The MRQ is 0.859. The company is less efficient in keeping operating costs low.
  • The TTM is 0.847. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.859TTM0.847+0.012
TTM0.847YOY0.820+0.027
TTM0.8475Y0.850-0.003
5Y0.85010Y0.832+0.018
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Bristol-Myers Squibb Company.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Bristol-Myers Squibb Company is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A Current Ratio of 1.16 means the company has €1.16 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Bristol-Myers Squibb Company:

  • The MRQ is 1.156. The company is just able to pay all its short-term debts.
  • The TTM is 1.218. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.156TTM1.218-0.062
TTM1.218YOY1.368-0.151
TTM1.2185Y1.550-0.333
5Y1.55010Y1.729-0.179
4.4.3.2. Quick Ratio

Measures if Bristol-Myers Squibb Company is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Bristol-Myers Squibb Company to the Drug Manufacturers - General industry mean.
  • A Quick Ratio of 0.81 means the company can pay off €0.81 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bristol-Myers Squibb Company:

  • The MRQ is 0.809. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.004. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ0.809TTM1.004-0.195
TTM1.004YOY1.168-0.164
TTM1.0045Y1.384-0.380
5Y1.38410Y1.689-0.305
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Bristol-Myers Squibb Company.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Bristol-Myers Squibb Company assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Bristol-Myers Squibb Company to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.82 means that Bristol-Myers Squibb Company assets are financed with 82.0% credit (debt) and the remaining percentage (100% - 82.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Bristol-Myers Squibb Company:

  • The MRQ is 0.820. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.756. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.820TTM0.756+0.064
TTM0.756YOY0.666+0.090
TTM0.7565Y0.676+0.080
5Y0.67610Y0.619+0.057
4.5.4.2. Debt to Equity Ratio

Measures if Bristol-Myers Squibb Company is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Bristol-Myers Squibb Company to the Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 455.9% means that company has €4.56 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bristol-Myers Squibb Company:

  • The MRQ is 4.559. The company is unable to pay all its debts with equity. -1
  • The TTM is 3.484. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ4.559TTM3.484+1.075
TTM3.484YOY2.000+1.484
TTM3.4845Y2.244+1.240
5Y2.24410Y1.749+0.495
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Bristol-Myers Squibb Company generates.

  • Above 15 is considered overpriced but always compare Bristol-Myers Squibb Company to the Drug Manufacturers - General industry mean.
  • A PE ratio of 13.11 means the investor is paying €13.11 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bristol-Myers Squibb Company:

  • The EOD is 15.050. Based on the earnings, the company is fair priced.
  • The MRQ is 13.113. Based on the earnings, the company is underpriced. +1
  • The TTM is 10.463. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD15.050MRQ13.113+1.937
MRQ13.113TTM10.463+2.650
TTM10.463YOY19.940-9.478
TTM10.4635Y-7.500+17.962
5Y-7.50010Y48.053-55.553
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Bristol-Myers Squibb Company:

  • The EOD is 11.083. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 9.656. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 8.019. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD11.083MRQ9.656+1.427
MRQ9.656TTM8.019+1.637
TTM8.019YOY13.776-5.757
TTM8.0195Y10.703-2.684
5Y10.70310Y17.613-6.910
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Bristol-Myers Squibb Company is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 4.67 means the investor is paying €4.67 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Bristol-Myers Squibb Company:

  • The EOD is 5.360. Based on the equity, the company is overpriced. -1
  • The MRQ is 4.670. Based on the equity, the company is fair priced.
  • The TTM is 4.480. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD5.360MRQ4.670+0.690
MRQ4.670TTM4.480+0.190
TTM4.480YOY4.383+0.097
TTM4.4805Y3.776+0.704
5Y3.77610Y6.038-2.262
4.6.2. Total Gains per Share

2.4. Latest News of Bristol-Myers Squibb Company

Does Bristol-Myers Squibb Company still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Bristol-Myers Squibb Company to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2024-08-30
23:45
Bristol Myers Squibb (BMY) Advances But Underperforms Market: Key FactsRead
2024-08-30
17:31
Exact Sciences (EXAS) Up 7.5% Since Last Earnings Report: Can It Continue?Read
2024-08-29
17:32
Neurocrine Stock Down 19% on Mixed Schizophrenia Study ResultsRead
2024-08-29
17:31
Repligen (RGEN) Down 13.1% Since Last Earnings Report: Can It Rebound?Read
2024-08-29
16:00
Bristol-Myers Squibb (NYSE:BMY) investors are sitting on a loss of 17% if they invested three years agoRead
2024-08-29
15:00
Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to KnowRead
2024-08-28
17:16
As Regulators Gear Up To Decide On Bristol Myers' Schizophrenia Treatment, Neurocrine Biosciences' Data Disappoints InvestorsRead
2024-08-27
12:59
Bristol Myers Squibb to Participate in Upcoming Investor ConferencesRead
2024-08-22
16:49
Bristol Myers' (BMY) HCC Combo Drug Accepted for FDA ReviewRead
2024-08-20
19:04
Bristol Myers' (BMY) Breyanzi Label Expansion Application ValidatedRead
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets94,646,000
Total Liabilities77,577,000
Total Stockholder Equity17,015,000
 As reported
Total Liabilities 77,577,000
Total Stockholder Equity+ 17,015,000
Total Assets = 94,646,000

Assets

Total Assets94,646,000
Total Current Assets26,890,000
Long-term Assets67,756,000
Total Current Assets
Cash And Cash Equivalents 6,293,000
Short-term Investments 360,000
Net Receivables 11,809,000
Inventory 3,077,000
Other Current Assets 5,351,000
Total Current Assets  (as reported)26,890,000
Total Current Assets  (calculated)26,890,000
+/-0
Long-term Assets
Property Plant Equipment 8,161,000
Goodwill 21,732,000
Long Term Investments 2,999,000
Intangible Assets 29,428,000
Long-term Assets Other 6,078,000
Long-term Assets  (as reported)67,756,000
Long-term Assets  (calculated)68,398,000
+/- 642,000

Liabilities & Shareholders' Equity

Total Current Liabilities23,265,000
Long-term Liabilities54,312,000
Total Stockholder Equity17,015,000
Total Current Liabilities
Short-term Debt 3,531,000
Short Long Term Debt 3,531,000
Accounts payable 3,751,000
Other Current Liabilities 15,983,000
Total Current Liabilities  (as reported)23,265,000
Total Current Liabilities  (calculated)26,796,000
+/- 3,531,000
Long-term Liabilities
Long term Debt 48,858,000
Capital Lease Obligations 1,615,000
Long-term Liabilities Other 576,000
Long-term Liabilities  (as reported)54,312,000
Long-term Liabilities  (calculated)51,049,000
+/- 3,263,000
Total Stockholder Equity
Common Stock292,000
Retained Earnings 16,103,000
Accumulated Other Comprehensive Income -1,456,000
Other Stockholders Equity 2,076,000
Total Stockholder Equity (as reported)17,015,000
Total Stockholder Equity (calculated)17,015,000
+/-0
Other
Capital Stock292,000
Cash and Short Term Investments 6,653,000
Common Stock Shares Outstanding 2,029,000
Liabilities and Stockholders Equity 94,646,000
Net Debt 47,534,000
Net Invested Capital 69,404,000
Net Working Capital 3,625,000
Property Plant and Equipment Gross 13,248,000
Short Long Term Debt Total 53,827,000



6.2. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-311995-12-311995-09-301995-06-301995-03-311994-12-311994-09-301994-06-301994-03-311993-12-311993-09-301993-06-301993-03-311992-12-311992-09-301992-06-301992-03-311991-12-311991-09-301991-06-301991-03-311990-12-311990-09-301990-06-301990-03-311989-12-311989-09-301989-06-301989-03-311988-12-311988-09-301988-06-301988-03-311987-12-311987-09-301987-06-301987-03-31
> Total Assets 
0
0
0
7,514,000
0
0
0
8,273,000
0
0
0
8,497,000
8,623,000
8,968,000
9,129,000
9,215,000
9,009,000
9,068,000
9,266,000
9,416,000
9,260,000
9,343,000
9,719,000
10,804,000
10,503,000
10,894,000
10,967,000
12,101,000
12,286,000
12,216,000
12,856,000
12,910,000
13,454,000
13,579,000
13,382,000
13,929,000
13,824,000
13,750,000
14,005,000
14,685,000
14,860,000
14,524,000
14,718,000
14,977,000
15,243,000
14,593,000
14,925,000
16,272,000
15,986,000
16,214,000
16,612,000
17,114,000
17,036,000
16,831,000
17,467,000
17,578,000
17,664,000
17,476,000
24,635,000
27,057,000
24,917,000
24,783,000
24,968,000
24,874,000
25,360,000
25,916,000
26,528,000
27,471,000
28,360,000
28,985,000
30,176,000
30,435,000
28,407,000
25,233,000
25,609,000
28,138,000
27,461,000
27,402,000
27,215,000
25,575,000
26,091,000
27,175,000
26,098,000
26,172,000
26,325,000
28,064,000
28,476,000
29,552,000
29,693,000
29,809,000
30,951,000
31,008,000
30,753,000
31,051,000
0
31,076,000
30,851,000
31,833,000
32,014,000
32,970,000
32,408,000
31,667,000
36,044,000
35,897,000
35,958,000
36,252,000
36,804,000
38,592,000
33,424,000
33,503,000
33,450,000
33,749,000
33,579,000
31,954,000
31,779,000
31,748,000
31,892,000
32,831,000
33,727,000
33,707,000
32,937,000
33,409,000
33,977,000
33,551,000
33,083,000
32,641,000
33,734,000
10,659,000
25,314,000
46,502,000
57,433,000
129,944,000
129,285,000
128,076,000
125,536,000
118,481,000
112,435,000
110,797,000
110,893,000
109,314,000
103,034,000
100,357,000
98,196,000
96,820,000
94,281,000
93,489,000
91,263,000
95,159,000
99,031,000
94,646,000
94,646,00099,031,00095,159,00091,263,00093,489,00094,281,00096,820,00098,196,000100,357,000103,034,000109,314,000110,893,000110,797,000112,435,000118,481,000125,536,000128,076,000129,285,000129,944,00057,433,00046,502,00025,314,00010,659,00033,734,00032,641,00033,083,00033,551,00033,977,00033,409,00032,937,00033,707,00033,727,00032,831,00031,892,00031,748,00031,779,00031,954,00033,579,00033,749,00033,450,00033,503,00033,424,00038,592,00036,804,00036,252,00035,958,00035,897,00036,044,00031,667,00032,408,00032,970,00032,014,00031,833,00030,851,00031,076,000031,051,00030,753,00031,008,00030,951,00029,809,00029,693,00029,552,00028,476,00028,064,00026,325,00026,172,00026,098,00027,175,00026,091,00025,575,00027,215,00027,402,00027,461,00028,138,00025,609,00025,233,00028,407,00030,435,00030,176,00028,985,00028,360,00027,471,00026,528,00025,916,00025,360,00024,874,00024,968,00024,783,00024,917,00027,057,00024,635,00017,476,00017,664,00017,578,00017,467,00016,831,00017,036,00017,114,00016,612,00016,214,00015,986,00016,272,00014,925,00014,593,00015,243,00014,977,00014,718,00014,524,00014,860,00014,685,00014,005,00013,750,00013,824,00013,929,00013,382,00013,579,00013,454,00012,910,00012,856,00012,216,00012,286,00012,101,00010,967,00010,894,00010,503,00010,804,0009,719,0009,343,0009,260,0009,416,0009,266,0009,068,0009,009,0009,215,0009,129,0008,968,0008,623,0008,497,0000008,273,0000007,514,000000
   > Total Current Assets 
0
0
0
5,006,000
0
0
0
5,422,000
0
0
0
5,552,000
5,611,000
5,954,000
6,095,000
5,670,000
5,466,000
5,468,000
5,574,000
5,567,000
5,400,000
5,360,000
5,637,000
6,621,000
6,262,000
6,618,000
6,675,000
6,570,000
6,729,000
6,644,000
6,675,000
6,710,000
6,864,000
6,890,000
6,610,000
7,018,000
6,762,000
6,729,000
6,935,000
7,528,000
7,790,000
7,540,000
7,657,000
7,736,000
7,995,000
7,313,000
7,720,000
8,782,000
8,497,000
8,658,000
8,957,000
9,267,000
9,046,000
8,939,000
9,671,000
9,824,000
9,751,000
9,519,000
9,473,000
12,349,000
9,940,000
9,948,000
10,573,000
9,975,000
10,519,000
10,659,000
11,366,000
11,918,000
12,732,000
13,168,000
13,883,000
14,801,000
12,656,000
9,352,000
10,145,000
12,283,000
11,584,000
11,804,000
11,648,000
10,302,000
10,558,000
11,544,000
10,594,000
10,348,000
10,580,000
12,836,000
14,779,000
14,763,000
15,375,000
14,570,000
13,387,000
13,958,000
12,532,000
12,983,000
0
13,273,000
13,296,000
14,775,000
14,869,000
15,318,000
11,765,000
11,013,000
9,278,000
9,521,000
10,076,000
10,486,000
10,627,000
18,916,000
14,014,000
14,062,000
14,177,000
14,608,000
14,925,000
13,056,000
12,926,000
10,415,000
11,215,000
12,298,000
13,204,000
13,704,000
13,615,000
14,324,000
15,048,000
14,854,000
14,649,000
13,874,000
14,869,000
8,884,000
17,093,000
37,716,000
40,191,000
29,354,000
31,853,000
34,343,000
34,277,000
30,192,000
27,111,000
29,161,000
31,443,000
33,262,000
30,121,000
30,186,000
26,796,000
27,273,000
27,086,000
28,074,000
27,632,000
31,770,000
28,669,000
26,890,000
26,890,00028,669,00031,770,00027,632,00028,074,00027,086,00027,273,00026,796,00030,186,00030,121,00033,262,00031,443,00029,161,00027,111,00030,192,00034,277,00034,343,00031,853,00029,354,00040,191,00037,716,00017,093,0008,884,00014,869,00013,874,00014,649,00014,854,00015,048,00014,324,00013,615,00013,704,00013,204,00012,298,00011,215,00010,415,00012,926,00013,056,00014,925,00014,608,00014,177,00014,062,00014,014,00018,916,00010,627,00010,486,00010,076,0009,521,0009,278,00011,013,00011,765,00015,318,00014,869,00014,775,00013,296,00013,273,000012,983,00012,532,00013,958,00013,387,00014,570,00015,375,00014,763,00014,779,00012,836,00010,580,00010,348,00010,594,00011,544,00010,558,00010,302,00011,648,00011,804,00011,584,00012,283,00010,145,0009,352,00012,656,00014,801,00013,883,00013,168,00012,732,00011,918,00011,366,00010,659,00010,519,0009,975,00010,573,0009,948,0009,940,00012,349,0009,473,0009,519,0009,751,0009,824,0009,671,0008,939,0009,046,0009,267,0008,957,0008,658,0008,497,0008,782,0007,720,0007,313,0007,995,0007,736,0007,657,0007,540,0007,790,0007,528,0006,935,0006,729,0006,762,0007,018,0006,610,0006,890,0006,864,0006,710,0006,675,0006,644,0006,729,0006,570,0006,675,0006,618,0006,262,0006,621,0005,637,0005,360,0005,400,0005,567,0005,574,0005,468,0005,466,0005,670,0006,095,0005,954,0005,611,0005,552,0000005,422,0000005,006,000000
       Cash And Cash Equivalents 
0
0
0
2,347,000
0
0
0
2,512,000
0
0
0
510,000
934,000
1,221,000
1,160,000
596,000
608,000
1,089,000
1,300,000
1,435,000
1,172,000
814,000
967,000
2,137,000
1,622,000
2,155,000
2,328,000
2,421,000
2,523,000
2,200,000
1,843,000
1,642,000
1,766,000
1,719,000
1,674,000
1,645,000
1,305,000
1,124,000
1,368,000
1,681,000
1,807,000
1,493,000
1,664,000
1,456,000
1,565,000
1,005,000
1,531,000
2,244,000
2,003,000
2,081,000
2,455,000
2,720,000
2,468,000
2,222,000
2,760,000
3,182,000
2,634,000
2,944,000
2,801,000
5,500,000
3,382,000
3,547,000
3,562,000
3,978,000
4,328,000
4,307,000
4,953,000
2,444,000
3,065,000
3,158,000
3,381,000
3,680,000
3,311,000
1,798,000
2,129,000
3,050,000
2,477,000
2,602,000
2,834,000
2,018,000
2,214,000
2,379,000
1,647,000
1,801,000
2,443,000
4,047,000
7,173,000
7,976,000
7,832,000
7,507,000
6,367,000
7,683,000
5,135,000
5,918,000
0
5,033,000
3,405,000
3,665,000
4,471,000
5,776,000
2,307,000
2,801,000
1,503,000
1,656,000
1,355,000
1,821,000
1,771,000
3,586,000
5,225,000
4,282,000
4,851,000
5,571,000
6,294,000
4,199,000
3,975,000
2,385,000
2,644,000
2,934,000
3,432,000
4,237,000
3,910,000
3,470,000
4,644,000
5,421,000
5,342,000
4,999,000
5,408,000
6,911,000
7,335,000
28,404,000
30,489,000
12,346,000
15,817,000
19,934,000
19,435,000
14,546,000
10,982,000
11,024,000
13,540,000
13,979,000
12,369,000
10,750,000
7,734,000
9,123,000
8,995,000
8,372,000
7,514,000
11,464,000
9,330,000
6,293,000
6,293,0009,330,00011,464,0007,514,0008,372,0008,995,0009,123,0007,734,00010,750,00012,369,00013,979,00013,540,00011,024,00010,982,00014,546,00019,435,00019,934,00015,817,00012,346,00030,489,00028,404,0007,335,0006,911,0005,408,0004,999,0005,342,0005,421,0004,644,0003,470,0003,910,0004,237,0003,432,0002,934,0002,644,0002,385,0003,975,0004,199,0006,294,0005,571,0004,851,0004,282,0005,225,0003,586,0001,771,0001,821,0001,355,0001,656,0001,503,0002,801,0002,307,0005,776,0004,471,0003,665,0003,405,0005,033,00005,918,0005,135,0007,683,0006,367,0007,507,0007,832,0007,976,0007,173,0004,047,0002,443,0001,801,0001,647,0002,379,0002,214,0002,018,0002,834,0002,602,0002,477,0003,050,0002,129,0001,798,0003,311,0003,680,0003,381,0003,158,0003,065,0002,444,0004,953,0004,307,0004,328,0003,978,0003,562,0003,547,0003,382,0005,500,0002,801,0002,944,0002,634,0003,182,0002,760,0002,222,0002,468,0002,720,0002,455,0002,081,0002,003,0002,244,0001,531,0001,005,0001,565,0001,456,0001,664,0001,493,0001,807,0001,681,0001,368,0001,124,0001,305,0001,645,0001,674,0001,719,0001,766,0001,642,0001,843,0002,200,0002,523,0002,421,0002,328,0002,155,0001,622,0002,137,000967,000814,0001,172,0001,435,0001,300,0001,089,000608,000596,0001,160,0001,221,000934,000510,0000002,512,0000002,347,000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
235,000
237,000
212,000
202,000
202,000
203,000
302,000
204,000
279,000
154,000
198,000
72,000
35,000
11,000
20,000
114,000
86,000
3,013,000
3,552,000
3,686,000
3,872,000
3,794,000
2,671,000
1,242,000
1,652,000
2,749,000
2,804,000
2,755,000
2,671,000
1,995,000
1,798,000
2,267,000
1,935,000
424,000
194,000
355,000
258,000
289,000
1,088,000
613,000
302,000
831,000
1,641,000
1,536,000
0
2,268,000
3,388,000
4,005,000
3,722,000
2,957,000
2,722,000
2,236,000
1,427,000
1,173,000
1,178,000
978,000
951,000
939,000
1,834,000
2,893,000
2,370,000
1,864,000
1,313,000
1,277,000
1,438,000
1,885,000
1,663,000
1,717,000
2,128,000
2,113,000
2,199,000
3,035,000
2,478,000
1,391,000
1,428,000
1,076,000
1,422,000
1,973,000
1,429,000
953,000
2,053,000
3,047,000
2,505,000
1,859,000
1,846,000
1,285,000
2,155,000
2,992,000
2,283,000
3,242,000
2,827,000
2,516,000
1,293,000
130,000
274,000
358,000
171,000
816,000
340,000
360,000
360,000340,000816,000171,000358,000274,000130,0001,293,0002,516,0002,827,0003,242,0002,283,0002,992,0002,155,0001,285,0001,846,0001,859,0002,505,0003,047,0002,053,000953,0001,429,0001,973,0001,422,0001,076,0001,428,0001,391,0002,478,0003,035,0002,199,0002,113,0002,128,0001,717,0001,663,0001,885,0001,438,0001,277,0001,313,0001,864,0002,370,0002,893,0001,834,000939,000951,000978,0001,178,0001,173,0001,427,0002,236,0002,722,0002,957,0003,722,0004,005,0003,388,0002,268,00001,536,0001,641,000831,000302,000613,0001,088,000289,000258,000355,000194,000424,0001,935,0002,267,0001,798,0001,995,0002,671,0002,755,0002,804,0002,749,0001,652,0001,242,0002,671,0003,794,0003,872,0003,686,0003,552,0003,013,00086,000114,00020,00011,00035,00072,000198,000154,000279,000204,000302,000203,000202,000202,000212,000237,000235,00000000000000000000000000000000000000000000000000000
       Net Receivables 
0
0
0
1,349,000
0
0
0
1,467,000
0
0
0
1,578,000
1,624,000
1,708,000
1,863,000
1,776,000
1,783,000
1,818,000
1,919,000
1,971,000
1,929,000
2,038,000
2,093,000
1,984,000
1,911,000
1,857,000
1,861,000
1,859,000
1,786,000
1,847,000
1,972,000
2,043,000
2,078,000
2,234,000
2,189,000
2,356,000
2,386,000
2,468,000
2,451,000
2,651,000
2,715,000
2,775,000
2,806,000
2,973,000
3,035,000
3,122,000
3,129,000
3,190,000
3,164,000
3,218,000
3,306,000
3,272,000
3,349,000
3,575,000
3,782,000
3,662,000
3,946,000
3,551,000
3,738,000
3,949,000
3,599,000
3,470,000
3,617,000
2,968,000
3,187,000
3,211,000
3,588,000
3,646,000
3,106,000
3,508,000
3,808,000
4,373,000
3,647,000
3,315,000
3,305,000
3,378,000
3,236,000
3,326,000
2,945,000
3,247,000
3,381,000
3,632,000
3,704,000
4,240,000
4,541,000
4,469,000
4,224,000
3,710,000
3,600,000
3,619,000
3,699,000
3,164,000
3,459,000
3,172,000
0
3,480,000
3,587,000
4,059,000
3,687,000
3,743,000
3,613,000
2,825,000
2,889,000
3,083,000
3,308,000
3,406,000
3,673,000
3,360,000
3,316,000
3,315,000
3,321,000
3,390,000
3,458,000
3,672,000
3,908,000
4,299,000
4,957,000
5,622,000
5,597,000
5,543,000
5,494,000
5,782,000
5,922,000
6,300,000
5,683,000
5,559,000
5,871,000
5,965,000
5,704,000
5,667,000
5,510,000
7,685,000
8,290,000
7,855,000
8,062,000
8,501,000
8,660,000
11,275,000
11,738,000
12,516,000
11,103,000
12,540,000
13,240,000
13,937,000
13,405,000
15,059,000
15,647,000
15,264,000
14,060,000
11,809,000
11,809,00014,060,00015,264,00015,647,00015,059,00013,405,00013,937,00013,240,00012,540,00011,103,00012,516,00011,738,00011,275,0008,660,0008,501,0008,062,0007,855,0008,290,0007,685,0005,510,0005,667,0005,704,0005,965,0005,871,0005,559,0005,683,0006,300,0005,922,0005,782,0005,494,0005,543,0005,597,0005,622,0004,957,0004,299,0003,908,0003,672,0003,458,0003,390,0003,321,0003,315,0003,316,0003,360,0003,673,0003,406,0003,308,0003,083,0002,889,0002,825,0003,613,0003,743,0003,687,0004,059,0003,587,0003,480,00003,172,0003,459,0003,164,0003,699,0003,619,0003,600,0003,710,0004,224,0004,469,0004,541,0004,240,0003,704,0003,632,0003,381,0003,247,0002,945,0003,326,0003,236,0003,378,0003,305,0003,315,0003,647,0004,373,0003,808,0003,508,0003,106,0003,646,0003,588,0003,211,0003,187,0002,968,0003,617,0003,470,0003,599,0003,949,0003,738,0003,551,0003,946,0003,662,0003,782,0003,575,0003,349,0003,272,0003,306,0003,218,0003,164,0003,190,0003,129,0003,122,0003,035,0002,973,0002,806,0002,775,0002,715,0002,651,0002,451,0002,468,0002,386,0002,356,0002,189,0002,234,0002,078,0002,043,0001,972,0001,847,0001,786,0001,859,0001,861,0001,857,0001,911,0001,984,0002,093,0002,038,0001,929,0001,971,0001,919,0001,818,0001,783,0001,776,0001,863,0001,708,0001,624,0001,578,0000001,467,0000001,349,000000
       Other Current Assets 
0
0
0
377,000
0
0
0
399,000
0
0
0
2,325,000
1,886,000
1,785,000
1,768,000
1,932,000
1,689,000
1,122,000
883,000
710,000
743,000
888,000
945,000
1,010,000
1,308,000
1,147,000
1,021,000
968,000
1,035,000
1,181,000
1,468,000
1,628,000
1,532,000
1,465,000
1,309,000
1,566,000
1,587,000
1,582,000
1,572,000
1,527,000
1,530,000
1,464,000
1,368,000
1,508,000
1,553,000
1,374,000
1,285,000
1,475,000
1,375,000
1,315,000
909,000
912,000
971,000
923,000
1,075,000
946,000
931,000
911,000
985,000
1,259,000
1,203,000
1,213,000
1,624,000
1,445,000
1,450,000
1,326,000
1,018,000
1,214,000
1,364,000
1,142,000
1,057,000
1,124,000
1,102,000
1,004,000
1,006,000
1,046,000
920,000
916,000
901,000
963,000
1,069,000
1,042,000
1,039,000
560,000
1,066,000
808,000
1,069,000
1,023,000
1,120,000
1,051,000
1,195,000
611,000
1,013,000
1,092,000
0
1,288,000
1,594,000
1,554,000
1,632,000
1,458,000
1,660,000
1,630,000
1,762,000
1,952,000
2,444,000
2,496,000
2,592,000
9,533,000
1,984,000
1,906,000
2,070,000
2,223,000
2,423,000
2,604,000
2,475,000
625,000
615,000
588,000
565,000
570,000
628,000
820,000
754,000
576,000
965,000
998,000
886,000
1,116,000
1,342,000
1,384,000
947,000
1,983,000
2,405,000
1,376,000
1,352,000
1,368,000
1,584,000
1,559,000
1,579,000
1,290,000
1,563,000
2,085,000
2,291,000
1,596,000
1,754,000
1,868,000
1,810,000
1,509,000
1,952,000
5,351,000
5,351,0001,952,0001,509,0001,810,0001,868,0001,754,0001,596,0002,291,0002,085,0001,563,0001,290,0001,579,0001,559,0001,584,0001,368,0001,352,0001,376,0002,405,0001,983,000947,0001,384,0001,342,0001,116,000886,000998,000965,000576,000754,000820,000628,000570,000565,000588,000615,000625,0002,475,0002,604,0002,423,0002,223,0002,070,0001,906,0001,984,0009,533,0002,592,0002,496,0002,444,0001,952,0001,762,0001,630,0001,660,0001,458,0001,632,0001,554,0001,594,0001,288,00001,092,0001,013,000611,0001,195,0001,051,0001,120,0001,023,0001,069,000808,0001,066,000560,0001,039,0001,042,0001,069,000963,000901,000916,000920,0001,046,0001,006,0001,004,0001,102,0001,124,0001,057,0001,142,0001,364,0001,214,0001,018,0001,326,0001,450,0001,445,0001,624,0001,213,0001,203,0001,259,000985,000911,000931,000946,0001,075,000923,000971,000912,000909,0001,315,0001,375,0001,475,0001,285,0001,374,0001,553,0001,508,0001,368,0001,464,0001,530,0001,527,0001,572,0001,582,0001,587,0001,566,0001,309,0001,465,0001,532,0001,628,0001,468,0001,181,0001,035,000968,0001,021,0001,147,0001,308,0001,010,000945,000888,000743,000710,000883,0001,122,0001,689,0001,932,0001,768,0001,785,0001,886,0002,325,000000399,000000377,000000
   > Long-term Assets 
0
0
0
2,508,000
0
0
0
2,851,000
0
0
0
2,945,000
3,012,000
3,014,000
3,034,000
3,545,000
3,543,000
3,600,000
3,692,000
3,849,000
3,860,000
3,983,000
4,082,000
4,183,000
4,241,000
4,276,000
4,292,000
5,531,000
5,557,000
5,572,000
6,181,000
6,200,000
6,590,000
6,689,000
6,772,000
6,911,000
7,062,000
7,021,000
7,070,000
7,157,000
7,070,000
6,984,000
7,061,000
7,241,000
7,248,000
7,280,000
7,205,000
7,490,000
7,489,000
7,556,000
7,655,000
7,847,000
7,990,000
7,892,000
7,796,000
7,754,000
7,913,000
7,957,000
15,162,000
14,708,000
14,977,000
14,835,000
14,395,000
14,899,000
14,841,000
15,257,000
15,162,000
15,553,000
15,628,000
15,817,000
16,293,000
15,634,000
15,751,000
15,881,000
15,464,000
15,855,000
15,877,000
15,598,000
15,567,000
15,273,000
15,533,000
15,631,000
15,504,000
15,824,000
15,745,000
15,228,000
13,697,000
14,789,000
14,318,000
15,239,000
17,564,000
17,050,000
18,221,000
18,068,000
0
17,803,000
17,555,000
17,058,000
17,145,000
17,652,000
20,643,000
20,654,000
26,766,000
26,376,000
25,882,000
25,766,000
26,177,000
19,676,000
19,410,000
19,441,000
19,273,000
19,141,000
18,654,000
18,898,000
18,853,000
21,333,000
20,677,000
20,533,000
20,523,000
20,003,000
19,322,000
19,085,000
18,929,000
18,697,000
18,434,000
18,767,000
18,865,000
1,775,000
17,741,000
17,447,000
17,242,000
100,590,000
97,432,000
93,733,000
91,259,000
88,289,000
85,324,000
81,636,000
79,450,000
76,052,000
72,913,000
70,171,000
71,400,000
69,547,000
67,195,000
65,415,000
63,631,000
63,389,000
70,362,000
67,756,000
67,756,00070,362,00063,389,00063,631,00065,415,00067,195,00069,547,00071,400,00070,171,00072,913,00076,052,00079,450,00081,636,00085,324,00088,289,00091,259,00093,733,00097,432,000100,590,00017,242,00017,447,00017,741,0001,775,00018,865,00018,767,00018,434,00018,697,00018,929,00019,085,00019,322,00020,003,00020,523,00020,533,00020,677,00021,333,00018,853,00018,898,00018,654,00019,141,00019,273,00019,441,00019,410,00019,676,00026,177,00025,766,00025,882,00026,376,00026,766,00020,654,00020,643,00017,652,00017,145,00017,058,00017,555,00017,803,000018,068,00018,221,00017,050,00017,564,00015,239,00014,318,00014,789,00013,697,00015,228,00015,745,00015,824,00015,504,00015,631,00015,533,00015,273,00015,567,00015,598,00015,877,00015,855,00015,464,00015,881,00015,751,00015,634,00016,293,00015,817,00015,628,00015,553,00015,162,00015,257,00014,841,00014,899,00014,395,00014,835,00014,977,00014,708,00015,162,0007,957,0007,913,0007,754,0007,796,0007,892,0007,990,0007,847,0007,655,0007,556,0007,489,0007,490,0007,205,0007,280,0007,248,0007,241,0007,061,0006,984,0007,070,0007,157,0007,070,0007,021,0007,062,0006,911,0006,772,0006,689,0006,590,0006,200,0006,181,0005,572,0005,557,0005,531,0004,292,0004,276,0004,241,0004,183,0004,082,0003,983,0003,860,0003,849,0003,692,0003,600,0003,543,0003,545,0003,034,0003,014,0003,012,0002,945,0000002,851,0000002,508,000000
       Property Plant Equipment 
0
0
0
1,927,000
0
0
0
2,188,000
0
0
0
2,350,000
2,403,000
2,433,000
2,510,000
2,631,000
2,622,000
2,670,000
2,751,000
2,936,000
2,957,000
3,072,000
3,166,000
3,141,000
3,133,000
3,192,000
3,233,000
3,374,000
3,394,000
3,449,000
3,484,000
3,666,000
3,701,000
3,744,000
3,790,000
3,760,000
3,765,000
3,798,000
3,877,000
3,964,000
3,922,000
3,975,000
3,994,000
4,156,000
4,183,000
4,205,000
4,248,000
4,429,000
4,429,000
4,455,000
4,489,000
4,621,000
4,550,000
4,512,000
4,431,000
4,548,000
4,600,000
4,681,000
4,685,000
4,879,000
4,920,000
5,063,000
5,243,000
5,321,000
5,349,000
5,416,000
5,480,000
5,712,000
5,719,000
5,658,000
5,655,000
5,765,000
5,673,000
5,642,000
5,649,000
5,693,000
5,669,000
5,701,000
5,715,000
5,673,000
5,709,000
5,768,000
5,853,000
5,650,000
5,567,000
5,403,000
5,360,000
5,405,000
5,386,000
5,468,000
5,561,000
5,055,000
4,822,000
4,745,000
0
4,664,000
4,604,000
4,554,000
4,492,000
4,521,000
4,512,000
4,478,000
5,297,000
5,333,000
5,259,000
5,228,000
5,236,000
4,579,000
4,485,000
4,438,000
4,387,000
4,417,000
4,323,000
4,363,000
4,249,000
4,412,000
4,455,000
4,597,000
4,790,000
4,980,000
5,020,000
4,944,000
5,014,000
5,001,000
5,060,000
5,080,000
5,092,000
5,027,000
4,985,000
4,849,000
4,830,000
6,252,000
6,112,000
5,777,000
6,458,000
6,745,000
6,613,000
6,801,000
6,835,000
6,968,000
6,941,000
6,810,000
6,918,000
7,475,000
7,605,000
7,629,000
7,848,000
8,036,000
8,186,000
8,161,000
8,161,0008,186,0008,036,0007,848,0007,629,0007,605,0007,475,0006,918,0006,810,0006,941,0006,968,0006,835,0006,801,0006,613,0006,745,0006,458,0005,777,0006,112,0006,252,0004,830,0004,849,0004,985,0005,027,0005,092,0005,080,0005,060,0005,001,0005,014,0004,944,0005,020,0004,980,0004,790,0004,597,0004,455,0004,412,0004,249,0004,363,0004,323,0004,417,0004,387,0004,438,0004,485,0004,579,0005,236,0005,228,0005,259,0005,333,0005,297,0004,478,0004,512,0004,521,0004,492,0004,554,0004,604,0004,664,00004,745,0004,822,0005,055,0005,561,0005,468,0005,386,0005,405,0005,360,0005,403,0005,567,0005,650,0005,853,0005,768,0005,709,0005,673,0005,715,0005,701,0005,669,0005,693,0005,649,0005,642,0005,673,0005,765,0005,655,0005,658,0005,719,0005,712,0005,480,0005,416,0005,349,0005,321,0005,243,0005,063,0004,920,0004,879,0004,685,0004,681,0004,600,0004,548,0004,431,0004,512,0004,550,0004,621,0004,489,0004,455,0004,429,0004,429,0004,248,0004,205,0004,183,0004,156,0003,994,0003,975,0003,922,0003,964,0003,877,0003,798,0003,765,0003,760,0003,790,0003,744,0003,701,0003,666,0003,484,0003,449,0003,394,0003,374,0003,233,0003,192,0003,133,0003,141,0003,166,0003,072,0002,957,0002,936,0002,751,0002,670,0002,622,0002,631,0002,510,0002,433,0002,403,0002,350,0000002,188,0000001,927,000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,436,000
1,420,000
1,401,000
1,377,000
5,200,000
5,225,000
5,091,000
4,865,000
4,864,000
4,864,000
1,826,000
4,829,000
4,836,000
4,831,000
4,897,000
4,908,000
4,905,000
4,905,000
4,825,000
4,824,000
4,823,000
4,822,000
4,829,000
4,828,000
4,829,000
4,831,000
4,831,000
4,831,000
4,998,000
4,997,000
4,877,000
4,841,000
4,827,000
4,827,000
4,827,000
5,475,000
5,218,000
5,218,000
5,218,000
0
5,233,000
5,233,000
5,233,000
5,564,000
5,586,000
6,799,000
6,799,000
7,498,000
7,635,000
7,646,000
7,646,000
7,646,000
7,096,000
7,046,000
7,046,000
7,046,000
7,027,000
7,027,000
6,976,000
6,952,000
6,881,000
6,875,000
6,875,000
6,875,000
6,875,000
6,875,000
6,861,000
6,865,000
6,863,000
6,863,000
6,683,000
6,686,000
6,538,000
6,536,000
6,533,000
6,513,000
22,488,000
22,452,000
20,578,000
20,517,000
20,547,000
20,524,000
20,529,000
20,519,000
20,502,000
20,500,000
20,446,000
21,112,000
21,149,000
21,162,000
21,163,000
21,147,000
21,169,000
21,738,000
21,732,000
21,732,00021,738,00021,169,00021,147,00021,163,00021,162,00021,149,00021,112,00020,446,00020,500,00020,502,00020,519,00020,529,00020,524,00020,547,00020,517,00020,578,00022,452,00022,488,0006,513,0006,533,0006,536,0006,538,0006,686,0006,683,0006,863,0006,863,0006,865,0006,861,0006,875,0006,875,0006,875,0006,875,0006,875,0006,881,0006,952,0006,976,0007,027,0007,027,0007,046,0007,046,0007,046,0007,096,0007,646,0007,646,0007,646,0007,635,0007,498,0006,799,0006,799,0005,586,0005,564,0005,233,0005,233,0005,233,00005,218,0005,218,0005,218,0005,475,0004,827,0004,827,0004,827,0004,841,0004,877,0004,997,0004,998,0004,831,0004,831,0004,831,0004,829,0004,828,0004,829,0004,822,0004,823,0004,824,0004,825,0004,905,0004,905,0004,908,0004,897,0004,831,0004,836,0004,829,0001,826,0004,864,0004,864,0004,865,0005,091,0005,225,0005,200,0001,377,0001,401,0001,420,0001,436,0000000000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,719,000
2,685,000
2,643,000
2,616,000
2,765,000
2,581,000
2,900,000
2,917,000
2,449,000
1,233,000
994,000
925,000
767,000
651,000
4,407,000
4,661,000
4,509,000
4,636,000
3,765,000
4,784,000
2,713,000
2,185,000
1,973,000
1,959,000
2,187,000
2,005,000
1,991,000
1,882,000
2,063,000
2,226,000
2,999,000
2,999,0002,226,0002,063,0001,882,0001,991,0002,005,0002,187,0001,959,0001,973,0002,185,0002,713,0004,784,0003,765,0004,636,0004,509,0004,661,0004,407,000651,000767,000925,000994,0001,233,0002,449,0002,917,0002,900,0002,581,0002,765,0002,616,0002,643,0002,685,0002,719,00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
209,000
0
0
0
228,000
0
0
0
224,000
0
0
0
192,000
0
0
0
170,000
0
0
0
153,000
0
0
0
191,000
0
0
0
939,000
1,207,000
1,201,000
1,178,000
1,219,000
1,419,000
1,430,000
1,434,000
1,508,000
1,531,000
1,513,000
1,623,000
1,625,000
1,606,000
1,611,000
1,580,000
1,587,000
1,568,000
1,590,000
1,550,000
1,502,000
1,483,000
1,463,000
1,445,000
1,436,000
0
0
0
2,247,000
2,200,000
2,126,000
1,931,000
1,904,000
1,848,000
4,864,000
1,782,000
1,732,000
1,933,000
1,909,000
1,921,000
1,866,000
2,170,000
2,083,000
1,988,000
1,921,000
2,061,000
2,029,000
1,933,000
1,852,000
1,775,000
1,707,000
1,632,000
1,330,000
1,286,000
1,245,000
1,212,000
1,151,000
1,107,000
1,070,000
2,726,000
2,865,000
2,813,000
2,763,000
0
3,370,000
3,299,000
3,222,000
3,196,000
3,124,000
4,816,000
4,569,000
9,217,000
8,778,000
8,570,000
8,370,000
8,176,000
2,318,000
2,208,000
1,843,000
1,718,000
1,753,000
1,706,000
1,563,000
1,544,000
1,419,000
1,380,000
1,379,000
1,377,000
1,385,000
1,276,000
1,245,000
1,213,000
1,210,000
1,116,000
1,090,000
1,107,000
1,091,000
1,026,000
995,000
1,002,000
63,969,000
61,666,000
59,171,000
56,698,000
53,243,000
50,819,000
48,065,000
44,930,000
42,775,000
40,422,000
38,262,000
38,726,000
36,355,000
34,054,000
31,773,000
29,377,000
27,485,000
33,167,000
29,428,000
29,428,00033,167,00027,485,00029,377,00031,773,00034,054,00036,355,00038,726,00038,262,00040,422,00042,775,00044,930,00048,065,00050,819,00053,243,00056,698,00059,171,00061,666,00063,969,0001,002,000995,0001,026,0001,091,0001,107,0001,090,0001,116,0001,210,0001,213,0001,245,0001,276,0001,385,0001,377,0001,379,0001,380,0001,419,0001,544,0001,563,0001,706,0001,753,0001,718,0001,843,0002,208,0002,318,0008,176,0008,370,0008,570,0008,778,0009,217,0004,569,0004,816,0003,124,0003,196,0003,222,0003,299,0003,370,00002,763,0002,813,0002,865,0002,726,0001,070,0001,107,0001,151,0001,212,0001,245,0001,286,0001,330,0001,632,0001,707,0001,775,0001,852,0001,933,0002,029,0002,061,0001,921,0001,988,0002,083,0002,170,0001,866,0001,921,0001,909,0001,933,0001,732,0001,782,0004,864,0001,848,0001,904,0001,931,0002,126,0002,200,0002,247,0000001,436,0001,445,0001,463,0001,483,0001,502,0001,550,0001,590,0001,568,0001,587,0001,580,0001,611,0001,606,0001,625,0001,623,0001,513,0001,531,0001,508,0001,434,0001,430,0001,419,0001,219,0001,178,0001,201,0001,207,000939,000000191,000000153,000000170,000000192,000000224,000000228,000000209,000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,048,000
848,000
3,392,000
3,221,000
2,858,000
2,814,000
3,014,000
3,063,000
2,721,000
-9,520,000
-8,661,000
2,902,000
3,005,000
2,683,000
3,094,000
2,925,000
3,245,000
2,732,000
2,476,000
2,382,000
3,342,000
3,184,000
3,252,000
3,232,000
2,877,000
2,854,000
0
0
0
0
0
000002,854,0002,877,0003,232,0003,252,0003,184,0003,342,0002,382,0002,476,0002,732,0003,245,0002,925,0003,094,0002,683,0003,005,0002,902,000-8,661,000-9,520,0002,721,0003,063,0003,014,0002,814,0002,858,0003,221,0003,392,000848,0001,048,00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
2,759,000
0
0
0
3,325,000
0
0
0
3,413,000
3,427,000
3,686,000
3,754,000
3,797,000
3,626,000
3,623,000
3,572,000
3,621,000
3,426,000
3,407,000
3,543,000
4,784,000
4,368,000
4,692,000
4,717,000
6,161,000
6,287,000
6,246,000
6,695,000
7,206,000
7,495,000
7,368,000
7,065,000
8,107,000
7,888,000
7,685,000
7,656,000
8,115,000
8,099,000
7,707,000
7,791,000
7,758,000
8,058,000
7,349,000
7,378,000
8,696,000
8,236,000
8,154,000
8,171,000
8,469,000
8,227,000
7,914,000
8,311,000
8,398,000
8,222,000
7,937,000
14,700,000
16,321,000
14,183,000
14,069,000
15,772,000
15,907,000
16,063,000
16,302,000
16,463,000
17,685,000
17,827,000
18,554,000
19,513,000
20,233,000
18,026,000
14,432,000
14,341,000
16,930,000
15,905,000
15,690,000
15,626,000
15,584,000
15,830,000
16,413,000
14,945,000
15,610,000
15,764,000
17,286,000
15,538,000
17,311,000
16,564,000
15,873,000
16,580,000
16,223,000
15,520,000
15,477,000
0
15,438,000
14,950,000
15,688,000
15,578,000
17,103,000
16,162,000
15,855,000
22,144,000
22,259,000
22,259,000
21,879,000
22,090,000
23,356,000
17,893,000
18,124,000
18,249,000
18,766,000
17,890,000
16,663,000
16,506,000
17,324,000
17,341,000
17,753,000
17,946,000
17,360,000
18,402,000
18,588,000
19,063,000
21,704,000
20,177,000
20,223,000
19,984,000
7,349,000
9,997,000
30,351,000
39,679,000
78,246,000
79,308,000
78,916,000
75,306,000
80,599,000
74,762,000
73,923,000
73,609,000
73,308,000
71,389,000
67,696,000
65,462,000
65,702,000
62,395,000
61,459,000
62,201,000
65,674,000
82,483,000
77,577,000
77,577,00082,483,00065,674,00062,201,00061,459,00062,395,00065,702,00065,462,00067,696,00071,389,00073,308,00073,609,00073,923,00074,762,00080,599,00075,306,00078,916,00079,308,00078,246,00039,679,00030,351,0009,997,0007,349,00019,984,00020,223,00020,177,00021,704,00019,063,00018,588,00018,402,00017,360,00017,946,00017,753,00017,341,00017,324,00016,506,00016,663,00017,890,00018,766,00018,249,00018,124,00017,893,00023,356,00022,090,00021,879,00022,259,00022,259,00022,144,00015,855,00016,162,00017,103,00015,578,00015,688,00014,950,00015,438,000015,477,00015,520,00016,223,00016,580,00015,873,00016,564,00017,311,00015,538,00017,286,00015,764,00015,610,00014,945,00016,413,00015,830,00015,584,00015,626,00015,690,00015,905,00016,930,00014,341,00014,432,00018,026,00020,233,00019,513,00018,554,00017,827,00017,685,00016,463,00016,302,00016,063,00015,907,00015,772,00014,069,00014,183,00016,321,00014,700,0007,937,0008,222,0008,398,0008,311,0007,914,0008,227,0008,469,0008,171,0008,154,0008,236,0008,696,0007,378,0007,349,0008,058,0007,758,0007,791,0007,707,0008,099,0008,115,0007,656,0007,685,0007,888,0008,107,0007,065,0007,368,0007,495,0007,206,0006,695,0006,246,0006,287,0006,161,0004,717,0004,692,0004,368,0004,784,0003,543,0003,407,0003,426,0003,621,0003,572,0003,623,0003,626,0003,797,0003,754,0003,686,0003,427,0003,413,0000003,325,0000002,759,000000
   > Total Current Liabilities 
0
0
0
2,129,000
0
0
0
2,613,000
0
0
0
2,659,000
2,666,000
2,728,000
2,771,000
2,821,000
2,687,000
2,737,000
2,680,000
2,752,000
2,555,000
2,631,000
2,701,000
3,300,000
2,902,000
2,892,000
2,919,000
3,065,000
3,161,000
3,175,000
3,739,000
4,274,000
4,589,000
4,399,000
4,211,000
4,806,000
4,760,000
4,766,000
4,815,000
5,050,000
5,141,000
4,865,000
4,708,000
5,032,000
5,193,000
4,601,000
4,645,000
5,791,000
5,319,000
5,367,000
5,401,000
5,537,000
5,317,000
5,131,000
5,559,000
5,632,000
5,498,000
5,261,000
7,047,000
8,826,000
6,807,000
6,760,000
8,138,000
8,220,000
8,298,000
8,430,000
7,612,000
7,530,000
7,550,000
8,443,000
9,085,000
9,843,000
7,849,000
6,627,000
6,622,000
6,890,000
6,000,000
5,829,000
6,165,000
6,496,000
6,307,000
6,689,000
8,051,000
8,644,000
8,443,000
8,640,000
6,951,000
6,710,000
6,633,000
6,744,000
7,392,000
6,313,000
6,017,000
5,908,000
0
6,739,000
6,755,000
7,410,000
7,313,000
7,780,000
7,211,000
6,991,000
8,195,000
8,279,000
8,414,000
8,354,000
8,279,000
12,440,000
7,521,000
7,798,000
8,103,000
8,461,000
7,689,000
7,435,000
7,158,000
8,017,000
7,597,000
7,885,000
8,996,000
8,841,000
8,494,000
9,017,000
9,438,000
9,563,000
9,624,000
9,878,000
9,694,000
1,703,000
8,841,000
9,711,000
10,489,000
18,304,000
19,232,000
23,421,000
20,464,000
19,080,000
17,330,000
18,991,000
21,460,000
21,868,000
22,821,000
20,915,000
18,930,000
21,890,000
19,085,000
20,150,000
23,462,000
22,262,000
25,822,000
23,265,000
23,265,00025,822,00022,262,00023,462,00020,150,00019,085,00021,890,00018,930,00020,915,00022,821,00021,868,00021,460,00018,991,00017,330,00019,080,00020,464,00023,421,00019,232,00018,304,00010,489,0009,711,0008,841,0001,703,0009,694,0009,878,0009,624,0009,563,0009,438,0009,017,0008,494,0008,841,0008,996,0007,885,0007,597,0008,017,0007,158,0007,435,0007,689,0008,461,0008,103,0007,798,0007,521,00012,440,0008,279,0008,354,0008,414,0008,279,0008,195,0006,991,0007,211,0007,780,0007,313,0007,410,0006,755,0006,739,00005,908,0006,017,0006,313,0007,392,0006,744,0006,633,0006,710,0006,951,0008,640,0008,443,0008,644,0008,051,0006,689,0006,307,0006,496,0006,165,0005,829,0006,000,0006,890,0006,622,0006,627,0007,849,0009,843,0009,085,0008,443,0007,550,0007,530,0007,612,0008,430,0008,298,0008,220,0008,138,0006,760,0006,807,0008,826,0007,047,0005,261,0005,498,0005,632,0005,559,0005,131,0005,317,0005,537,0005,401,0005,367,0005,319,0005,791,0004,645,0004,601,0005,193,0005,032,0004,708,0004,865,0005,141,0005,050,0004,815,0004,766,0004,760,0004,806,0004,211,0004,399,0004,589,0004,274,0003,739,0003,175,0003,161,0003,065,0002,919,0002,892,0002,902,0003,300,0002,701,0002,631,0002,555,0002,752,0002,680,0002,737,0002,687,0002,821,0002,771,0002,728,0002,666,0002,659,0000002,613,0000002,129,000000
       Short-term Debt 
0
0
0
415,000
0
0
0
679,000
0
0
0
281,000
282,000
323,000
322,000
397,000
331,000
404,000
444,000
553,000
449,000
445,000
407,000
375,000
311,000
257,000
0
177,000
210,000
221,000
755,000
725,000
796,000
832,000
699,000
575,000
526,000
496,000
530,000
513,000
591,000
622,000
540,000
543,000
542,000
453,000
504,000
482,000
535,000
546,000
512,000
432,000
365,000
258,000
173,000
162,000
181,000
162,000
1,734,000
174,000
308,000
785,000
799,000
1,379,000
2,247,000
1,902,000
1,288,000
127,000
776,000
1,009,000
1,650,000
1,883,000
244,000
292,000
277,000
231,000
234,000
189,000
630,000
187,000
241,000
256,000
1,879,000
1,891,000
1,781,000
1,799,000
135,000
154,000
156,000
124,000
286,000
231,000
208,000
290,000
0
117,000
135,000
187,000
182,000
115,000
145,000
236,000
751,000
826,000
1,372,000
764,000
680,000
359,000
281,000
365,000
401,000
590,000
330,000
755,000
642,000
139,000
106,000
155,000
990,000
992,000
1,197,000
1,306,000
1,461,000
987,000
1,925,000
1,716,000
1,620,000
1,703,000
421,000
612,000
635,000
3,479,000
3,998,000
4,954,000
3,721,000
2,504,000
1,937,000
2,828,000
5,238,000
5,117,000
7,693,000
5,120,000
2,299,000
4,400,000
2,923,000
3,188,000
5,617,000
3,281,000
6,359,000
3,531,000
3,531,0006,359,0003,281,0005,617,0003,188,0002,923,0004,400,0002,299,0005,120,0007,693,0005,117,0005,238,0002,828,0001,937,0002,504,0003,721,0004,954,0003,998,0003,479,000635,000612,000421,0001,703,0001,620,0001,716,0001,925,000987,0001,461,0001,306,0001,197,000992,000990,000155,000106,000139,000642,000755,000330,000590,000401,000365,000281,000359,000680,000764,0001,372,000826,000751,000236,000145,000115,000182,000187,000135,000117,0000290,000208,000231,000286,000124,000156,000154,000135,0001,799,0001,781,0001,891,0001,879,000256,000241,000187,000630,000189,000234,000231,000277,000292,000244,0001,883,0001,650,0001,009,000776,000127,0001,288,0001,902,0002,247,0001,379,000799,000785,000308,000174,0001,734,000162,000181,000162,000173,000258,000365,000432,000512,000546,000535,000482,000504,000453,000542,000543,000540,000622,000591,000513,000530,000496,000526,000575,000699,000832,000796,000725,000755,000221,000210,000177,0000257,000311,000375,000407,000445,000449,000553,000444,000404,000331,000397,000322,000323,000282,000281,000000679,000000415,000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
992,000
1,197,000
8,217,000
8,443,000
7,962,000
1,245,000
1,261,000
1,247,000
1,249,000
381,000
545,000
569,000
3,346,000
3,862,000
4,819,000
3,585,000
2,340,000
1,777,000
2,655,000
5,065,000
4,948,000
7,522,000
4,953,000
2,132,000
4,264,000
2,752,000
3,020,000
5,467,000
3,119,000
6,190,000
3,531,000
3,531,0006,190,0003,119,0005,467,0003,020,0002,752,0004,264,0002,132,0004,953,0007,522,0004,948,0005,065,0002,655,0001,777,0002,340,0003,585,0004,819,0003,862,0003,346,000569,000545,000381,0001,249,0001,247,0001,261,0001,245,0007,962,0008,443,0008,217,0001,197,000992,00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
0
475,000
394,000
414,000
416,000
530,000
526,000
490,000
455,000
537,000
525,000
540,000
515,000
562,000
503,000
523,000
0
649,000
632,000
619,000
578,000
693,000
773,000
745,000
759,000
848,000
843,000
896,000
794,000
1,064,000
1,014,000
968,000
980,000
1,017,000
1,116,000
1,071,000
1,067,000
1,380,000
1,271,000
1,373,000
1,506,000
1,657,000
1,514,000
1,586,000
1,430,000
1,702,000
1,608,000
1,629,000
1,432,000
1,587,000
1,438,000
1,483,000
1,427,000
1,553,000
1,509,000
1,830,000
1,663,000
1,893,000
1,687,000
1,718,000
1,812,000
2,127,000
1,873,000
1,320,000
1,342,000
1,579,000
1,244,000
1,263,000
1,174,000
1,239,000
1,315,000
1,406,000
1,343,000
1,442,000
1,575,000
1,628,000
1,441,000
1,535,000
1,695,000
1,802,000
1,796,000
1,711,000
1,752,000
1,681,000
0
1,983,000
2,036,000
2,401,000
2,292,000
2,603,000
2,385,000
2,134,000
2,085,000
2,202,000
2,079,000
2,346,000
2,466,000
2,559,000
2,502,000
2,405,000
2,568,000
2,487,000
2,346,000
1,839,000
1,249,000
1,565,000
1,543,000
1,504,000
1,407,000
1,664,000
1,503,000
1,551,000
1,699,000
2,248,000
1,725,000
1,873,000
1,773,000
1,892,000
1,976,000
2,005,000
1,888,000
2,445,000
3,069,000
2,852,000
2,441,000
2,713,000
2,972,000
3,609,000
2,695,000
2,949,000
2,944,000
2,882,000
2,595,000
3,040,000
3,194,000
3,069,000
2,813,000
3,259,000
3,539,000
3,751,000
3,751,0003,539,0003,259,0002,813,0003,069,0003,194,0003,040,0002,595,0002,882,0002,944,0002,949,0002,695,0003,609,0002,972,0002,713,0002,441,0002,852,0003,069,0002,445,0001,888,0002,005,0001,976,0001,892,0001,773,0001,873,0001,725,0002,248,0001,699,0001,551,0001,503,0001,664,0001,407,0001,504,0001,543,0001,565,0001,249,0001,839,0002,346,0002,487,0002,568,0002,405,0002,502,0002,559,0002,466,0002,346,0002,079,0002,202,0002,085,0002,134,0002,385,0002,603,0002,292,0002,401,0002,036,0001,983,00001,681,0001,752,0001,711,0001,796,0001,802,0001,695,0001,535,0001,441,0001,628,0001,575,0001,442,0001,343,0001,406,0001,315,0001,239,0001,174,0001,263,0001,244,0001,579,0001,342,0001,320,0001,873,0002,127,0001,812,0001,718,0001,687,0001,893,0001,663,0001,830,0001,509,0001,553,0001,427,0001,483,0001,438,0001,587,0001,432,0001,629,0001,608,0001,702,0001,430,0001,586,0001,514,0001,657,0001,506,0001,373,0001,271,0001,380,0001,067,0001,071,0001,116,0001,017,000980,000968,0001,014,0001,064,000794,000896,000843,000848,000759,000745,000773,000693,000578,000619,000632,000649,0000523,000503,000562,000515,000540,000525,000537,000455,000490,000526,000530,000416,000414,000394,000475,00000000000000
       Other Current Liabilities 
0
0
0
1,714,000
0
0
0
1,934,000
0
0
0
1,903,000
1,990,000
1,991,000
2,033,000
1,894,000
1,830,000
1,843,000
1,781,000
1,662,000
1,581,000
1,646,000
1,779,000
2,363,000
2,088,000
2,112,000
2,919,000
2,239,000
2,319,000
2,335,000
2,406,000
2,856,000
3,020,000
2,822,000
2,753,000
3,383,000
3,391,000
3,374,000
3,491,000
3,473,000
3,536,000
3,275,000
3,188,000
3,472,000
3,535,000
3,077,000
3,074,000
3,929,000
3,513,000
3,448,000
3,383,000
3,448,000
3,438,000
3,287,000
3,956,000
3,768,000
847,000
700,000
1,072,000
2,858,000
1,211,000
982,000
4,755,000
4,818,000
4,368,000
4,588,000
4,578,000
5,434,000
5,038,000
5,668,000
5,586,000
5,801,000
5,721,000
1,151,000
1,033,000
1,085,000
924,000
724,000
758,000
4,659,000
4,364,000
4,584,000
4,402,000
4,864,000
4,471,000
4,471,000
4,543,000
4,744,000
4,461,000
4,551,000
5,034,000
4,134,000
3,792,000
3,662,000
0
4,237,000
4,237,000
4,539,000
4,518,000
4,725,000
4,394,000
4,264,000
4,670,000
4,426,000
4,191,000
4,258,000
4,130,000
8,766,000
3,677,000
3,938,000
4,139,000
4,217,000
3,554,000
3,902,000
4,304,000
5,310,000
4,783,000
5,044,000
5,276,000
5,423,000
4,957,000
5,423,000
5,631,000
6,245,000
5,857,000
6,201,000
6,208,000
-2,064,000
6,341,000
7,002,000
7,880,000
7,888,000
8,061,000
11,004,000
11,124,000
10,241,000
9,407,000
9,540,000
10,164,000
10,109,000
12,184,000
12,913,000
14,036,000
14,450,000
12,968,000
10,102,000
11,167,000
11,498,000
12,064,000
15,983,000
15,983,00012,064,00011,498,00011,167,00010,102,00012,968,00014,450,00014,036,00012,913,00012,184,00010,109,00010,164,0009,540,0009,407,00010,241,00011,124,00011,004,0008,061,0007,888,0007,880,0007,002,0006,341,000-2,064,0006,208,0006,201,0005,857,0006,245,0005,631,0005,423,0004,957,0005,423,0005,276,0005,044,0004,783,0005,310,0004,304,0003,902,0003,554,0004,217,0004,139,0003,938,0003,677,0008,766,0004,130,0004,258,0004,191,0004,426,0004,670,0004,264,0004,394,0004,725,0004,518,0004,539,0004,237,0004,237,00003,662,0003,792,0004,134,0005,034,0004,551,0004,461,0004,744,0004,543,0004,471,0004,471,0004,864,0004,402,0004,584,0004,364,0004,659,000758,000724,000924,0001,085,0001,033,0001,151,0005,721,0005,801,0005,586,0005,668,0005,038,0005,434,0004,578,0004,588,0004,368,0004,818,0004,755,000982,0001,211,0002,858,0001,072,000700,000847,0003,768,0003,956,0003,287,0003,438,0003,448,0003,383,0003,448,0003,513,0003,929,0003,074,0003,077,0003,535,0003,472,0003,188,0003,275,0003,536,0003,473,0003,491,0003,374,0003,391,0003,383,0002,753,0002,822,0003,020,0002,856,0002,406,0002,335,0002,319,0002,239,0002,919,0002,112,0002,088,0002,363,0001,779,0001,646,0001,581,0001,662,0001,781,0001,843,0001,830,0001,894,0002,033,0001,991,0001,990,0001,903,0000001,934,0000001,714,000000
   > Long-term Liabilities 
0
0
0
630,000
0
0
0
712,000
0
0
0
754,000
761,000
958,000
983,000
976,000
939,000
886,000
892,000
869,000
871,000
776,000
842,000
1,484,000
1,466,000
1,800,000
1,798,000
3,096,000
3,126,000
3,071,000
2,956,000
2,932,000
2,906,000
2,969,000
2,854,000
3,301,000
3,128,000
2,919,000
2,841,000
3,065,000
2,958,000
2,842,000
3,083,000
2,726,000
2,865,000
2,748,000
2,733,000
2,905,000
2,917,000
2,787,000
2,770,000
2,932,000
2,910,000
2,783,000
2,752,000
2,766,000
2,724,000
2,676,000
7,653,000
7,495,000
7,376,000
7,309,000
7,634,000
7,687,000
7,765,000
7,872,000
8,851,000
10,155,000
10,277,000
10,111,000
10,428,000
10,390,000
10,177,000
7,805,000
7,719,000
10,040,000
9,905,000
9,861,000
9,461,000
9,088,000
9,523,000
9,724,000
6,894,000
6,966,000
7,321,000
8,646,000
8,587,000
10,601,000
9,931,000
9,129,000
9,188,000
9,910,000
9,503,000
9,569,000
0
8,699,000
8,195,000
8,278,000
8,265,000
9,323,000
8,951,000
8,864,000
13,949,000
13,980,000
13,845,000
13,525,000
13,811,000
10,916,000
10,372,000
10,326,000
10,146,000
10,305,000
10,201,000
9,228,000
9,348,000
9,307,000
9,744,000
9,868,000
8,950,000
8,519,000
9,908,000
9,571,000
9,625,000
12,141,000
10,553,000
10,345,000
10,290,000
5,646,000
10,676,000
29,301,000
29,190,000
59,942,000
60,076,000
55,495,000
54,842,000
61,519,000
57,432,000
54,932,000
52,149,000
51,440,000
48,568,000
46,781,000
46,532,000
43,812,000
43,310,000
41,309,000
38,739,000
43,412,000
56,661,000
54,312,000
54,312,00056,661,00043,412,00038,739,00041,309,00043,310,00043,812,00046,532,00046,781,00048,568,00051,440,00052,149,00054,932,00057,432,00061,519,00054,842,00055,495,00060,076,00059,942,00029,190,00029,301,00010,676,0005,646,00010,290,00010,345,00010,553,00012,141,0009,625,0009,571,0009,908,0008,519,0008,950,0009,868,0009,744,0009,307,0009,348,0009,228,00010,201,00010,305,00010,146,00010,326,00010,372,00010,916,00013,811,00013,525,00013,845,00013,980,00013,949,0008,864,0008,951,0009,323,0008,265,0008,278,0008,195,0008,699,00009,569,0009,503,0009,910,0009,188,0009,129,0009,931,00010,601,0008,587,0008,646,0007,321,0006,966,0006,894,0009,724,0009,523,0009,088,0009,461,0009,861,0009,905,00010,040,0007,719,0007,805,00010,177,00010,390,00010,428,00010,111,00010,277,00010,155,0008,851,0007,872,0007,765,0007,687,0007,634,0007,309,0007,376,0007,495,0007,653,0002,676,0002,724,0002,766,0002,752,0002,783,0002,910,0002,932,0002,770,0002,787,0002,917,0002,905,0002,733,0002,748,0002,865,0002,726,0003,083,0002,842,0002,958,0003,065,0002,841,0002,919,0003,128,0003,301,0002,854,0002,969,0002,906,0002,932,0002,956,0003,071,0003,126,0003,096,0001,798,0001,800,0001,466,0001,484,000842,000776,000871,000869,000892,000886,000939,000976,000983,000958,000761,000754,000000712,000000630,000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,256,000
2,143,000
2,660,000
2,643,000
5,166,000
4,778,000
4,674,000
4,603,000
4,559,000
4,512,000
4,352,000
4,294,000
15,882,000
16,544,000
12,939,000
12,755,000
12,340,000
12,100,000
11,467,000
11,543,000
10,961,000
10,266,000
8,850,000
8,721,000
7,392,000
0
0
0
0
0
0
0000007,392,0008,721,0008,850,00010,266,00010,961,00011,543,00011,467,00012,100,00012,340,00012,755,00012,939,00016,544,00015,882,0004,294,0004,352,0004,512,0004,559,0004,603,0004,674,0004,778,0005,166,0002,643,0002,660,0002,143,0002,256,00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
547,000
528,000
512,000
492,000
454,000
447,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
248,000
319,000
572,000
547,000
496,000
0
470,000
0
0
0
0
0000470,0000496,000547,000572,000319,000248,00000000000000000447,000454,000492,000512,000528,000547,00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
4,755,000
0
0
0
4,948,000
0
0
0
5,084,000
5,196,000
5,282,000
5,375,000
5,418,000
5,383,000
5,445,000
5,694,000
5,795,000
5,834,000
5,936,000
6,176,000
6,020,000
6,135,000
6,202,000
6,250,000
5,940,000
5,999,000
5,970,000
6,161,000
5,704,000
5,959,000
6,211,000
6,317,000
5,822,000
5,936,000
6,065,000
6,349,000
6,570,000
6,761,000
6,817,000
6,927,000
7,219,000
7,185,000
7,244,000
7,547,000
7,576,000
7,750,000
8,060,000
8,441,000
8,645,000
8,809,000
8,917,000
9,156,000
9,180,000
9,442,000
9,539,000
9,935,000
10,736,000
10,734,000
10,714,000
9,196,000
8,967,000
9,297,000
9,614,000
10,065,000
9,786,000
10,533,000
10,431,000
10,663,000
10,202,000
10,381,000
10,801,000
11,268,000
11,208,000
11,556,000
11,712,000
11,589,000
9,991,000
10,261,000
10,762,000
11,153,000
10,562,000
10,561,000
10,778,000
12,938,000
12,241,000
13,337,000
14,096,000
14,518,000
14,843,000
15,249,000
15,668,000
0
15,713,000
15,998,000
16,353,000
16,572,000
15,956,000
16,337,000
16,098,000
13,900,000
13,623,000
13,659,000
14,371,000
14,726,000
15,154,000
15,473,000
15,327,000
15,143,000
14,852,000
15,546,000
15,123,000
15,079,000
14,266,000
14,386,000
14,918,000
15,613,000
16,177,000
14,416,000
14,699,000
14,783,000
11,741,000
12,793,000
12,317,000
13,640,000
14,031,000
15,218,000
16,049,000
17,648,000
51,598,000
49,911,000
49,094,000
50,158,000
37,822,000
37,605,000
36,808,000
37,213,000
35,946,000
31,580,000
32,600,000
32,671,000
31,061,000
31,824,000
31,973,000
28,998,000
29,430,000
16,490,000
17,015,000
17,015,00016,490,00029,430,00028,998,00031,973,00031,824,00031,061,00032,671,00032,600,00031,580,00035,946,00037,213,00036,808,00037,605,00037,822,00050,158,00049,094,00049,911,00051,598,00017,648,00016,049,00015,218,00014,031,00013,640,00012,317,00012,793,00011,741,00014,783,00014,699,00014,416,00016,177,00015,613,00014,918,00014,386,00014,266,00015,079,00015,123,00015,546,00014,852,00015,143,00015,327,00015,473,00015,154,00014,726,00014,371,00013,659,00013,623,00013,900,00016,098,00016,337,00015,956,00016,572,00016,353,00015,998,00015,713,000015,668,00015,249,00014,843,00014,518,00014,096,00013,337,00012,241,00012,938,00010,778,00010,561,00010,562,00011,153,00010,762,00010,261,0009,991,00011,589,00011,712,00011,556,00011,208,00011,268,00010,801,00010,381,00010,202,00010,663,00010,431,00010,533,0009,786,00010,065,0009,614,0009,297,0008,967,0009,196,00010,714,00010,734,00010,736,0009,935,0009,539,0009,442,0009,180,0009,156,0008,917,0008,809,0008,645,0008,441,0008,060,0007,750,0007,576,0007,547,0007,244,0007,185,0007,219,0006,927,0006,817,0006,761,0006,570,0006,349,0006,065,0005,936,0005,822,0006,317,0006,211,0005,959,0005,704,0006,161,0005,970,0005,999,0005,940,0006,250,0006,202,0006,135,0006,020,0006,176,0005,936,0005,834,0005,795,0005,694,0005,445,0005,383,0005,418,0005,375,0005,282,0005,196,0005,084,0000004,948,0000004,755,000000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
219,000
219,000
219,000
219,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
0
220,000
220,000
220,000
220,000
220,000
221,000
221,000
221,000
221,000
221,000
221,000
221,000
221,000
221,000
221,000
221,000
221,000
221,000
221,000
221,000
221,000
221,000
221,000
221,000
221,000
221,000
221,000
221,000
221,000
221,000
221,000
221,000
221,000
221,000
221,000
221,000
292,000
292,000
292,000
292,000
292,000
292,000
292,000
292,000
292,000
292,000
292,000
292,000
292,000
292,000
292,000
292,000
292,000
292,000
292,000
292,000292,000292,000292,000292,000292,000292,000292,000292,000292,000292,000292,000292,000292,000292,000292,000292,000292,000292,000221,000221,000221,000221,000221,000221,000221,000221,000221,000221,000221,000221,000221,000221,000221,000221,000221,000221,000221,000221,000221,000221,000221,000221,000221,000221,000221,000221,000221,000221,000221,000220,000220,000220,000220,000220,0000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000219,000219,000219,000219,00000000000000000000000000000000000000000000000000000
   Retained Earnings Total Equity000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income -1,456,000-1,400,000-1,546,000-1,286,000-1,387,000-1,368,000-1,281,000-841,000-992,000-1,229,000-1,268,000-1,424,000-1,518,000-1,544,000-1,839,000-1,699,000-1,556,000-1,549,000-1,520,000-1,463,000-2,621,000-2,644,000-2,762,000-2,326,000-2,334,000-2,234,000-2,289,000-2,421,000-2,467,000-2,414,000-2,503,000-2,735,000-2,804,000-2,693,000-2,468,000-2,395,000-2,173,000-2,416,000-2,425,000-2,605,000-2,225,000-2,267,000-2,141,000-2,312,000-2,520,000-3,131,000-3,202,000-2,944,000-2,967,000-3,018,000-3,045,000-2,282,000-2,389,000-2,414,000-2,371,0000-2,300,000-2,425,000-2,541,000-2,218,000-2,255,000-2,605,000-2,719,000-1,430,000-1,604,000-1,646,000-1,558,000-1,515,000-1,554,000-1,594,000-1,645,000-710,000-774,000-775,000-836,000-810,000-847,000-770,000-849,000-754,000-764,000-644,000-910,000-935,000-1,030,000-1,004,000-1,102,000-1,037,000-1,082,000-1,174,000-1,117,000-1,127,000-1,047,000-1,004,000-1,103,000-982,000-978,000-870,000-816,000-796,000-3,158,000-3,113,000-3,079,000-2,973,000-2,929,000-2,843,000-2,845,000-2,791,000-2,808,000-2,723,000-2,682,000-2,686,000-2,624,000-2,576,000-2,504,000-2,333,000-2,329,000-2,259,000-2,170,000-2,139,000-1,996,000-1,929,000-1,862,000-1,943,000-1,943,000-1,935,000-1,891,000-1,920,000-1,856,000-1,825,000-1,782,000-1,750,000-1,692,000-1,674,000-1,640,000-1,595,000-1,553,000-1,522,000-1,454,000000-1,158,000000-1,023,000000
   Capital Surplus 000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
1,184,000
0
0
0
899,000
0
0
0
1,742,000
1,790,000
1,768,000
1,687,000
1,630,000
1,449,000
1,352,000
1,407,000
1,342,000
1,235,000
1,237,000
1,308,000
1,142,000
1,099,000
1,025,000
1,049,400
559,000
478,000
345,000
425,000
274,000
337,000
427,000
219,000
409,000
248,000
147,000
116,000
-8,000
-206,000
-423,000
-807,000
-886,000
-1,461,000
-1,763,000
-1,994,000
-1,885,000
-2,316,000
-2,487,000
-5,356,000
-5,758,000
-6,276,000
-6,667,000
-7,180,000
-7,718,000
-8,354,000
-8,880,000
-8,914,000
-9,053,000
-9,041,000
-9,051,000
-9,010,000
-9,011,000
-8,998,000
-8,991,000
-8,976,000
-8,963,000
-8,902,000
-8,867,000
-8,859,000
-8,820,000
-8,707,000
-8,668,000
-8,654,000
-8,640,000
-8,516,000
-8,477,000
-8,452,000
-8,429,000
-8,376,000
-8,065,000
-8,015,000
-7,862,000
-7,821,000
-7,795,000
-7,771,000
-7,809,000
-6,849,000
-6,805,000
-6,771,000
-13,596,000
-13,495,000
-13,574,000
0
-13,772,000
-13,863,000
-13,870,000
-14,163,000
-14,288,000
-14,461,000
-14,817,000
-15,758,000
-16,129,000
-16,192,000
-16,045,000
-16,009,000
-15,878,000
-15,772,000
-15,695,000
-15,620,000
-15,485,000
-15,369,000
-15,286,000
-15,193,000
-15,100,000
-15,318,000
-15,205,000
-15,145,000
-15,054,000
-17,049,000
-16,989,000
-17,158,000
-17,351,000
-17,517,000
-17,614,000
-17,547,000
-17,493,000
-17,468,000
-17,421,000
-17,665,000
18,352,000
18,497,000
18,793,000
19,151,000
18,088,000
16,653,000
15,866,000
15,720,000
13,102,000
8,569,000
9,083,000
8,545,000
6,547,000
6,332,000
5,619,000
1,774,000
1,918,000
1,958,000
2,076,000
2,076,0001,958,0001,918,0001,774,0005,619,0006,332,0006,547,0008,545,0009,083,0008,569,00013,102,00015,720,00015,866,00016,653,00018,088,00019,151,00018,793,00018,497,00018,352,000-17,665,000-17,421,000-17,468,000-17,493,000-17,547,000-17,614,000-17,517,000-17,351,000-17,158,000-16,989,000-17,049,000-15,054,000-15,145,000-15,205,000-15,318,000-15,100,000-15,193,000-15,286,000-15,369,000-15,485,000-15,620,000-15,695,000-15,772,000-15,878,000-16,009,000-16,045,000-16,192,000-16,129,000-15,758,000-14,817,000-14,461,000-14,288,000-14,163,000-13,870,000-13,863,000-13,772,0000-13,574,000-13,495,000-13,596,000-6,771,000-6,805,000-6,849,000-7,809,000-7,771,000-7,795,000-7,821,000-7,862,000-8,015,000-8,065,000-8,376,000-8,429,000-8,452,000-8,477,000-8,516,000-8,640,000-8,654,000-8,668,000-8,707,000-8,820,000-8,859,000-8,867,000-8,902,000-8,963,000-8,976,000-8,991,000-8,998,000-9,011,000-9,010,000-9,051,000-9,041,000-9,053,000-8,914,000-8,880,000-8,354,000-7,718,000-7,180,000-6,667,000-6,276,000-5,758,000-5,356,000-2,487,000-2,316,000-1,885,000-1,994,000-1,763,000-1,461,000-886,000-807,000-423,000-206,000-8,000116,000147,000248,000409,000219,000427,000337,000274,000425,000345,000478,000559,0001,049,4001,025,0001,099,0001,142,0001,308,0001,237,0001,235,0001,342,0001,407,0001,352,0001,449,0001,630,0001,687,0001,768,0001,790,0001,742,000000899,0000001,184,000000



6.3. Balance Sheets

Currency in EUR. All numbers in thousands.




6.4. Cash Flows

Currency in EUR. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in EUR. All numbers in thousands.

Gross Profit (+$)
totalRevenue45,006,000
Cost of Revenue-10,693,000
Gross Profit34,313,00034,313,000
 
Operating Income (+$)
Gross Profit34,313,000
Operating Expense-26,118,000
Operating Income9,417,0008,195,000
 
Operating Expense (+$)
Research Development9,299,000
Selling General Administrative6,372,000
Selling And Marketing Expenses1,400,000
Operating Expense26,118,00017,071,000
 
Net Interest Income (+$)
Interest Income-
Interest Expense-1,166,000
Other Finance Cost-0
Net Interest Income-1,166,000
 
Pretax Income (+$)
Operating Income9,417,000
Net Interest Income-1,166,000
Other Non-Operating Income Expenses-
Income Before Tax (EBT)8,440,0008,006,000
EBIT - interestExpense = 8,251,000
8,425,000
9,191,000
Interest Expense1,166,000
Earnings Before Interest and Taxes (EBIT)9,417,0009,606,000
Earnings Before Interest and Taxes (EBITDA)19,177,000
 
After tax Income (+$)
Income Before Tax8,440,000
Tax Provision-400,000
Net Income From Continuing Ops8,040,0008,040,000
Net Income8,025,000
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses36,811,000
Total Other Income/Expenses Net1,411,0001,166,000
 

Technical Analysis of Bristol-Myers Squibb Company
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Bristol-Myers Squibb Company. The general trend of Bristol-Myers Squibb Company is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Bristol-Myers Squibb Company's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Bristol-Myers Squibb Company.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 45.58 < 46.95 < 48.78.

The bearish price targets are: 42.58 > 42.16 > 41.53.

Tweet this
Bristol-Myers Squibb Company Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Bristol-Myers Squibb Company. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Bristol-Myers Squibb Company Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Bristol-Myers Squibb Company. The current macd is 0.70067357.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Bristol-Myers Squibb Company price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Bristol-Myers Squibb Company. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Bristol-Myers Squibb Company price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Bristol-Myers Squibb Company Daily Moving Average Convergence/Divergence (MACD) ChartBristol-Myers Squibb Company Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Bristol-Myers Squibb Company. The current adx is 22.65.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Bristol-Myers Squibb Company shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Bristol-Myers Squibb Company Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Bristol-Myers Squibb Company. The current sar is 45.62.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Bristol-Myers Squibb Company Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Bristol-Myers Squibb Company. The current rsi is 61.83. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Bristol-Myers Squibb Company Daily Relative Strength Index (RSI) ChartBristol-Myers Squibb Company Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Bristol-Myers Squibb Company. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Bristol-Myers Squibb Company price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Bristol-Myers Squibb Company Daily Stochastic Oscillator ChartBristol-Myers Squibb Company Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Bristol-Myers Squibb Company. The current cci is 121.01.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Bristol-Myers Squibb Company Daily Commodity Channel Index (CCI) ChartBristol-Myers Squibb Company Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Bristol-Myers Squibb Company. The current cmo is 29.24.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Bristol-Myers Squibb Company Daily Chande Momentum Oscillator (CMO) ChartBristol-Myers Squibb Company Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Bristol-Myers Squibb Company. The current willr is -16.16666667.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Bristol-Myers Squibb Company Daily Williams %R ChartBristol-Myers Squibb Company Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Bristol-Myers Squibb Company.

Bristol-Myers Squibb Company Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Bristol-Myers Squibb Company. The current atr is 1.05702893.

Bristol-Myers Squibb Company Daily Average True Range (ATR) ChartBristol-Myers Squibb Company Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Bristol-Myers Squibb Company. The current obv is -85,735.

Bristol-Myers Squibb Company Daily On-Balance Volume (OBV) ChartBristol-Myers Squibb Company Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Bristol-Myers Squibb Company. The current mfi is 63.45.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Bristol-Myers Squibb Company Daily Money Flow Index (MFI) ChartBristol-Myers Squibb Company Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Bristol-Myers Squibb Company.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-22ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-26RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-04-29MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-05-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-27STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-05-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-06MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-06-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-06-10MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-06-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-06-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-06-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-24CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-06-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-06-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-06-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-07-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-07-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-07-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-19STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-24STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-25ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-26ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-29ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-05MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-13STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-16STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Bristol-Myers Squibb Company Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Bristol-Myers Squibb Company based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.830
Ma 20Greater thanMa 5043.807
Ma 50Greater thanMa 10041.314
Ma 100Greater thanMa 20040.645
OpenGreater thanClose44.940
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Bristol-Myers Squibb Company with someone you think should read this too:
  • Are you bullish or bearish on Bristol-Myers Squibb Company? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Bristol-Myers Squibb Company? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Bristol-Myers Squibb Company

I send you an email if I find something interesting about Bristol-Myers Squibb Company.


Comments

How you think about this?

Leave a comment

Stay informed about Bristol-Myers Squibb Company.

Receive notifications about Bristol-Myers Squibb Company in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.